trending Market Intelligence /marketintelligence/en/news-insights/trending/5jfrg0zvqklaqvej4rjcjw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medtronic to redeem $1.17B of debt

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Medtronic to redeem $1.17B of debt

Medtronic PLC plans to redeem about $1.17 billion of its senior notes, consisting of $400.0 million of its 5.600% senior notes due 2019 and $765.6 million of its 4.450% senior notes due 2020.

The redemption date for the notes will be April 27.

Medtronic also plans to repurchase a minimum of $1.2 billion of its ordinary shares over the course of its 2019 fiscal year.

The repurchases will be in addition to the company's planned share repurchases to offset employee compensation dilution and will be made under Medtronic's existing $5.0 billion share repurchase program authorized by the company's board.

Ireland-based Medtronic plans to fund the redemption of the notes and the repurchase of its ordinary shares with cash and cash equivalents on hand.